This federal contract award, with the ID SPE2DE20D0027|SPE2DE21F0145, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories. The contract is for the delivery of BinaxNOW COVID-19 antigen control products, which are critical diagnostic supplies used to support the government's response to the Coronavirus (COVID-19) pandemic. The contract is a firm fixed-price delivery order with a ceiling value of $10,237.65 and an ultimate completion date of March 11, 2021. This award is not associated with a set-aside program and is part of the larger medical supply chain efforts being undertaken by the DLA to procure COVID-19 testing and diagnostic materials for federal healthcare facilities, including the Department of Veterans Affairs (VA) and Department of Defense (DoD). Abbott Rapid DX North America LLC, as a subsidiary of the parent company Abbott Laboratories, is a major supplier of COVID-19 diagnostic products and medical technologies to various federal agencies.